AI validates molecular glue compound that kills lymphoma cells
Deep Origin’s docking and molecular dynamics (MD) simulations have successfully rationalised researchers’ work identifying a potent compound to switch on cell-death programmes in diffuse large B cell lymphoma (DLBCL). The study was led by researchers at Stanford University and the University of Texas MD Anderson Cancer Center. … Read More